Reza Asadzadeh1, Pedram Ahmadpoor2, Mohsen Nafar2, Shima Samavat2, Hassan Nikoueinejad3, Morteza Hosseinzadeh4, Nahid Mamizadeh5, Saeideh Hatami6, Elham Masoumi4, Aliakbar Amirzargar7. 1. Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. 4. Department of Immunology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran. 5. Department of Nephrology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran. 6. Department of Tissue Engineering and Regenerative Medicine, Iran university of Medical Sciences, Tehran, Iran. 7. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND: Cytomegalovirus (CMV) infection is the most common complications following kidney transplantation. Natural killer (NK) cells demonstrated critical anti-viral role in controlling and elimination of CMV after transplantation. Interleukin-15 (IL-15) is a pleiotropic cytokine that promotes the activity of NK cells and strengthens the acquired immune system. Also, IP10 (CXCL10) is a chemotactic factor which regulates NK cell recruitment and antiviral immune response. We aimed to determine the correlation between the serum levels of IL-15 and IP-10 cytokines with CMV infection, CMV viral load, and cyclosporine as a major immunosuppressive treatment after transplantation. METHODS: Fifty-eight kidney transplant recipient patients without evidence of CMV virus disease before transplantation surgery were included in the study. From the day of transplant surgery, the patients were evaluated based on the presence of CMV Ag pp65, CMV viral load, serum levels of IL-15 & IP-10, Cyclosporine levels (C0 & C2), Glomerular Filtration Rate (GFR), and hematological & biochemical Index, up to 75 days. RESULTS: Comparison analysis of serum levels of IL-15 and IP-10 showed no significant association with CMV infection in kidney transplant recipients. In addition, CMV viral load and cyclosporine levels at C0 and C2 did not affect patients' IL-15 and IP-10 levels. CONCLUSION: The levels of IP-10 and IL-15 cytokines are not affected with CMV infection, even if a viral infection occurs in the early days after transplantation or long afterwards. In addition, taking the different levels of cyclosporine did not affect the cytokines levels. Other mechanisms may play a role in maintaining the levels of these cytokines.
BACKGROUND: Cytomegalovirus (CMV) infection is the most common complications following kidney transplantation. Natural killer (NK) cells demonstrated critical anti-viral role in controlling and elimination of CMV after transplantation. Interleukin-15 (IL-15) is a pleiotropic cytokine that promotes the activity of NK cells and strengthens the acquired immune system. Also, IP10 (CXCL10) is a chemotactic factor which regulates NK cell recruitment and antiviral immune response. We aimed to determine the correlation between the serum levels of IL-15 and IP-10 cytokines with CMV infection, CMV viral load, and cyclosporine as a major immunosuppressive treatment after transplantation. METHODS: Fifty-eight kidney transplant recipient patients without evidence of CMV virus disease before transplantation surgery were included in the study. From the day of transplant surgery, the patients were evaluated based on the presence of CMV Ag pp65, CMV viral load, serum levels of IL-15 & IP-10, Cyclosporine levels (C0 & C2), Glomerular Filtration Rate (GFR), and hematological & biochemical Index, up to 75 days. RESULTS: Comparison analysis of serum levels of IL-15 and IP-10 showed no significant association with CMV infection in kidney transplant recipients. In addition, CMV viral load and cyclosporine levels at C0 and C2 did not affect patients' IL-15 and IP-10 levels. CONCLUSION: The levels of IP-10 and IL-15 cytokines are not affected with CMV infection, even if a viral infection occurs in the early days after transplantation or long afterwards. In addition, taking the different levels of cyclosporine did not affect the cytokines levels. Other mechanisms may play a role in maintaining the levels of these cytokines.
Authors: Vasileios Bekiaris; Olga Timoshenko; Tie Zheng Hou; Kai Toellner; Saba Shakib; Fabrina Gaspal; Fiona M McConnell; Sonia M Parnell; David Withers; Chris D Buckley; Clive Sweet; Wayne M Yokoyama; Graham Anderson; Peter J L Lane Journal: J Immunol Date: 2008-05-15 Impact factor: 5.422
Authors: L Weseslindtner; R Nachbagauer; M Kundi; P Jaksch; H Kerschner; B Simon; L Hatos-Agyi; A Scheed; J H Aberle; W Klepetko; E Puchhammer-Stöckl Journal: Am J Transplant Date: 2011-01-10 Impact factor: 8.086
Authors: Onder Alpdogan; Jeffrey M Eng; Stephanie J Muriglan; Lucy M Willis; Vanessa M Hubbard; Kartono H Tjoe; Theis H Terwey; Adam Kochman; Marcel R M van den Brink Journal: Blood Date: 2004-07-27 Impact factor: 22.113
Authors: Shivaprakash Gangappa; Kenneth E Kokko; Lisa M Carlson; Tania Gourley; Kenneth A Newell; Thomas C Pearson; Rafi Ahmed; Christian P Larsen Journal: Transpl Int Date: 2008-01-21 Impact factor: 3.782